Marshall Wace, LLP Immuno Precise Antibodies Ltd. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.64 - $6.49 $303,517 - $541,162	-83,384 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.06 - $6.69 $466,177 - $616,349	-92,130 Reduced 52.49%	83,384 $447,000
Q3 2021 Nov 15, 2021	BUY	$5.14 - $13.22 $715,770 - $1.84 Million	139,255 Added 384.06%	175,514 $1.09 Million
Q2 2021 Aug 13, 2021	BUY	$6.02 - $12.91 $17,072 - $36,612	2,836 Added 8.49%	36,259 $218,000
Q1 2021 May 17, 2021	BUY	$8.84 - $17.0 $295,459 - $568,191	33,423 New	33,423 $325,000

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $11.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.